New Study: Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults
VIETNAM, HO CHI MINH CITY – On 12 October 2023, the results of the ACT HIV trial – Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-positive Adults – were published in the New England Journal of Medicine. Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, kills around 1.5 million people each year. Tuberculous meningitis is the most […]
Large-scale Study Examines Impact of COVID-19 Pandemic on Tuberculosis Control in Indonesia
A new study published in The Lancet Global Health highlights the devastating impact of the COVID-19 pandemic on tuberculosis (TB) control in Indonesia, the nation with the second highest TB burden globally and the second highest burden of COVID-19 in the Asian region.